Apeiron RIA’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,935
| Closed | -$510K | – | 213 |
|
|
2024
Q4 | $510K | Buy |
5,935
+1,199
| +25% | +$103K | 0.14% | 120 |
|
|
2024
Q3 | $564K | Buy |
4,736
+56
| +1% | +$6.67K | 0.16% | 108 |
|
|
2024
Q2 | $668K | Sell |
4,680
-36
| -0.8% | -$5.14K | 0.2% | 87 |
|
|
2024
Q1 | $606K | Sell |
4,716
-198
| -4% | -$25.4K | 0.18% | 100 |
|
|
2023
Q4 | $508K | Buy |
4,914
+128
| +3% | +$13.2K | 0.16% | 106 |
|
|
2023
Q3 | $435K | Buy |
4,786
+58
| +1% | +$5.27K | 0.15% | 107 |
|
|
2023
Q2 | $382K | Buy |
4,728
+316
| +7% | +$25.6K | 0.13% | 118 |
|
|
2023
Q1 | $351K | Sell |
4,412
-1,368
| -24% | -$109K | 0.12% | 125 |
|
|
2022
Q4 | $391K | Buy |
5,780
+58
| +1% | +$3.93K | 0.15% | 107 |
|
|
2022
Q3 | $299K | Buy |
+5,722
| New | +$299K | 0.14% | 124 |
|
|
2022
Q2 | – | Sell |
-3,288
| Closed | -$200K | – | 183 |
|
|
2022
Q1 | $200K | Buy |
+3,288
| New | +$200K | 0.1% | 148 |
|